Volume 6 Issue 9, Sep 2021

ISSN: 2095-9907 

EISSN: 2059-23635 

2023 impact factor 40.8 

 (Clarivate Analytics, 2024)
Volume 6 Issue 9, Sep 2021:
Letter
Repurposing of a clinically used anti-HPV agent to prevent and treat SARS-CoV-2 infection as an intranasal formulation
Chen Hua,Qinhai Ma,Yun Zhu,Shuai Xia,Zezhong Liu,Lin Li,Lu Lu  ORCID: orcid.org/0000-0002-2255-0391,Nanshan Zhong,Shuwen Liu  ORCID: orcid.org/0000-0001-6346-5006,Zifeng Yang &…Shibo Jiang  ORCID: orcid.org/0000-0001-8283-7135